Principal Investigator
Peter Hosein
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230733
Clinical Trial Summary
Single patient expanded access use for the treatment of pancreatic adenocarcinoma with ELI-002 2P
Phase
N/A
Funding Agency/Sponsor
Institutional
Disease
Pancreatic, Liver, and Related Cancers
Contact Information
Phone Number
+1 (305) 2433462